Human Genomics (Jul 2021)

TMEM263: a novel candidate gene implicated in human autosomal recessive severe lethal skeletal dysplasia

  • Mahsa Sadat Asl Mohajeri,
  • Atieh Eslahi,
  • Zeinab Khazaii,
  • Mohammad Reza Moradi,
  • Reza Pazhoomand,
  • Shima Farrokhi,
  • Masoumeh Heidari Feizabadi,
  • Farzaneh Alizadeh,
  • Majid Mojarrad

DOI
https://doi.org/10.1186/s40246-021-00343-2
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Introduction Skeletal dysplasia is a common, clinically and genetically heterogeneous disorder in the human population. An increasing number of different genes are being identified causing this disorder. We used whole exome sequencing (WES) for detection of skeletal dysplasia causing mutation in a fetus affected to severe lethal skeletal dysplasia. Patient Fetus was assessed by ultrasonography in second trimester of pregnancy. He suffers from severe rhizomelic dysplasia and also pathologic shortening of ribs. WES was applied to finding of causal mutation. Furthermore, bioinformatics analysis was performed to predict mutation impact. Results Whole exome sequencing (WES) identified a homozygous frameshift mutation in the TMEM263 gene in a fetus with severe lethal skeletal dysplasia. Mutations of this gene have been previously identified in dwarf chickens, but this is the first report of involvement of this gene in human skeletal dysplasia. This gene plays a key role in the growth hormone signaling pathway. Conclusion TMEM263 can be considered as a new gene responsible for skeletal dysplasia. Given the complications observed in the affected fetus, the mutation of this gene appears to produce much more intense complications than that found in chickens and is likely to play a more important role in bone development in human.

Keywords